CtrlK
ChromaDex
CDXC80
$7.72arrow_drop_down1.40%-$0.11
NASDAQ - As of Mar 14, 1:50 AM EDT Market Closed
High Growth
CDXC80
$7.72
arrow_drop_down1.40%Performance History
arrow_drop_up221.66%
(+$5.32 )
| Key Stats | |
|---|---|
| Open | $7.70 |
| Prev. Close | $7.83 |
| EPS | 0.02 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $583.15M |
| PE Ratio | 386.00 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 7.34 | 8.30 |
| 52 Week Range | 1.25 | 9.15 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: just now
info
Analyzed by 17 Wall Street experts, ChromaDex's 12-month projections average at $7.08, spanning from a high of $16.00 to a low of $2.40. This signifies an -8.25% shift from the current price of $7.72.
Analyst Ratings
Buy
| Buy | 5 | 100.00% | |
|---|---|---|---|
| Hold | 0 | 0.00% | |
| Sell | 0 | 0.00% |
•Ratings from: March•
Last updated: just now
•Total: 5info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.
Correlated Companies
About ChromaDex (CDXC)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Robert N. Fried
- Headquarters
- Los Angeles
- Employees
- 113
- Exchange
- NASDAQ
Keep an eye on ChromaDex
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is ChromaDex's (CDXC) price per share?
The current price per share for ChromaDex (CDXC) is $7.72. The stock has seen a price change of -$0.11 recently, indicating a -1.4% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for ChromaDex (CDXC)?
For ChromaDex (CDXC), the 52-week high is $9.15, which is 18.54% from the current price. The 52-week low is $1.25, the current price is 517.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is ChromaDex (CDXC) a growth stock?
ChromaDex (CDXC) has shown an average price growth of -1.65% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ChromaDex as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is ChromaDex (CDXC) stock price performance year to date (YTD)?
As of the latest data, ChromaDex (CDXC) has a year-to-date price change of 45.52%. Over the past month, the stock has experienced a price change of 38.35%. Over the last three months, the change has been 26.14%. Over the past six months, the figure is 117.46%. Looking at a longer horizon, the five-year price change stands at 131.14%.
help
Is ChromaDex (CDXC) a profitable company?
ChromaDex (CDXC) has a net income of -$4.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.76% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 6.26% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $83.57M, with a revenue growth rate of 15.99%, providing insight into the company's sales performance and growth. The gross profit is $50.78M. Operating income is noted at -$5.6M. Furthermore, the EBITDA is $1.29M.
help
What is the market capitalization of ChromaDex (CDXC)?
ChromaDex (CDXC) has a market capitalization of $583.16M. The average daily trading volume is 7.6, indicating the stock's liquidity and investor engagement.